Development and validation of a high-performance liquid chromatography method for the estimation of esomeprazole in bulk and tablet dosage form
DOI:
https://doi.org/10.30827/ars.v64i3.27450Keywords:
Esomeprazole, Method development, System suitability parameters, ValidationAbstract
Introduction: An accurate, simple, precise, rapid, economic and reproducible reverse-phase high-performance liquid chromatography method was developed and validated for the estimation of Esomeprazole (ESO) in bulk and tablet dosage form.
Method: The separation was carried out on Finepak SIL C18T-5 column (250 × 4.6 mm, 5.0 µm i. d.) using potassium dihydrogen phosphate buffer (0.025M): ACN (20:80 v/v) and at a flow rate of 1.0 mL/min. using UV detector at 302 nm with a run time of 10 min. The method was validated for accuracy for linearity, accuracy, precision, limit of detection (LOD), limit of quantification (LOQ) and robustness.
Results: The standard calibration curve was linear with R2 = 0.995. LOD and LOQ obtained for esomeprazole were 0.0001 and 0.0004 µg/mL respectively. The method was found robust for possible changes. Results of analysis of other parameters were also tested and validated as per ICH guidelines and recovery studies confirmed the accuracy of the proposed method. validation studies showed that the developed HPLC method is simple, reproducible, rapid, precise and reliable. The high recovery and low relative standard deviation confirm the suitability of the developed method for the determination of esomeprazole in the tablet dosage form.
Conclusion: This method may be used as a more convenient and efficient option for the analysis of esomeprazole to establish the quality of the substance during routine analysis with consistent and reproducible results.
Downloads
References
Kaartinen TJ, Tornio A, Tapaninen T, Launiainen T, Isoherranen N, Niemi M, et al. Effect of high-dose esomeprazole on CYP1A2, CYP2C19, and CYP3A4 activities in humans: evidence for substantial and long-lasting inhibition of CYP2C19. Clin Pharmacol Ther. 2020;108(6):1254-64. doi:10.1002/cpt.1949.
Bellia GF, Gil-Ramirez G, Baron MG, Croxton R, Gonzalez-Rodriguez J. Analysis of omeprazole and esomeprazole obtained from traditional pharmacies and unlicensed internet websites using Raman spectroscopy, 1H-NMR and chemometric analysis. Vib Spectrosc. 2020;106:102996. doi:10.1016/j.vibspec.2019.102996.
Xu N, Zhu J, Wu Y-Q, Zhang Y, Xia J-Y, Zhao Q, et al. Enzymatic Preparation of the Chiral (S)-Sulfoxide Drug Esomeprazole at Pilot-Scale Levels. Org Process Res Dev. 2020;24(6):1124-30. doi:10.1021/acs.oprd.0c00115.
Thulluru A, Mahammed N, Basha SS, Mohan KSJ, Saravanakumar K, Kumar CSP. Effect of enzyme dependent polymers on the release profile of press coated esmeprazole colon targeted tablets. Res J Pharm Technol. 2020;13(12):6186-94. doi:10.5958/0974-360X.2020.01079.3
Zheng R-N. Comparative study of omeprazole, lansoprazole, pantoprazole and esomeprazole for symptom relief in patients with reflux esophagitis. World J Gastroenterol. 2009;15(8):990-5. doi:10.3748/wjg.15.990.
Lindberg P, Keeling D, Fryklund J, Andersson T, Lundborg P, Carlsson E. Esomeprazole—enhanced bio-availability, specificity for the proton pump and inhibition of acid secretion. Aliment Pharmacol Ther. 2003;17(4):481-8. doi:10.1046/j.1365-2036.2003.01481.x.
Jain V, Shah VK, Jain PK. HPLC method development and validation for the estimation of esomeprazole in bulk and pharmaceutical dosage form. J Drug Deliv Ther. 2019;9(4):292-5. doi:10.22270/jddt.v9i4.3046.
Shanmugakumar S, Begum N, Uday B. A Novel RP-HPLC method for determination of esomeprazole in pharmaceutical dosage forms in human plasma: a pilot stress degradation study. Asian J Pharm Anal. 2021;11(1):9-16. doi:10.5958/2231-5675.2021.00002.8.
Patel B, Suhagia B, Patel M, Patel J. Determination of pantoprazole, rabeprazole, esomeprazole, domperidone and itopride in pharmaceutical products by reversed phase liquid chromatography using single mobile phase. Chromatographia. 2007;65(11):743-8. doi:10.1365/s10337-007-0220-z.
Estevez P, Flor S, Boscolo O, Tripodi V, Lucangioli S. Development and validation of a capillary electrophoresis method for determination of enantiomeric purity and related substances of esomeprazole in raw material and pellets. Electrophoresis. 2014;35(6):804-10. doi:10.1002/elps.201300334.
Prabu SL, Shirwaikar A, Shirwaikar A, Kumar CD, Joseph A, Kumar R. Simultaneous estimation of esomeprazole and domperidone by UV spectrophotometric method. Indian J Pharm Sci. 2008;70(1):128-31. doi:10.4103/0250-474X.40351.
Mokhtar MM, Hammad SF, Mansour FR, El-Khateeb BZ. Simultaneous Determination of Diclofenac and Esomeprazole by Reversed phase Liquid Chromatography, Dual Wavelength and Derivative Spectrophotometry. J Anal Chem. 2019;74(5):458-66. doi:10.1134/S1061934819050071.
Gali H, Yerragunta V. Development and validation of RP-HPLC method for simultaneous estimation of naproxen and esomeprazole in pharmaceutical dosage form. Asian J Res Chem. 2016;9(8):366-8. doi:10.5958/0974-4150.2016.00055.9.
Reddy PS, Sait S, Vasudevmurthy G, Vishwanath B, Prasad V, Reddy SJ. Stability indicating simultaneous estimation of assay method for naproxen and esomeprazole in pharmaceutical formulations by RP-HPLC. Der Pharma Chem. 2011;3(6):553-64.
Prathyusha P, Sundararajan R, Bhanu P, Mukthinuthalapati MA. A new stability indicating RP-HPLC method for determination of Bilastine in bulk and pharmaceutical formulation. Res J Pharm Technol. 2020;13(6):2849-53. doi:10.5958/0974-360X.2020.00507.7.
Moni F, Sharmin S, Rony SR, Afroz F, Akhter S, Sohrab MH. Bioanalytical method validation of Esomeprazole by high performance liquid chromatography with PDA detection. Acta Chromatogr. 2021;33(2):120-6. doi:10.1556/1326.2020.00769.
Pydimarry SPR, Cholleti VK, Vangala RR. Stability-indicating UPLC method for determining related substances and degradants in dronedarone. J Chromatogr Sci. 2014;52(7):666-75. doi:10.1093/chromsci/bmt097.
Sojitra C, Rajput S. Development and validation of RP-HPLC methods for simultaneous estimation of naproxen and esomeprazole magnesium trihydrate in combined pharmaceutical formulation. Int J Pharm Pharm Sci. 2012;4(Suppl 3):533-7. doi:10.4103/2229-4708.90356.
Kayesh R, Sultan MZ. A Novel Ion-Pair RP-HPLC Method for Simultaneous Quantification of Naproxen and Esomeprazole in Pharmaceutical Formulations. J Chromatogr Sci. 2014;53(5):687-93. doi:10.1093/chromsci/bmu103.
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Ujjwala Kandekar, Trushal V. Chorge, Sagar B. Wankhede, Vinod H. Nimbalkar, Hemlata M. Nimje
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The articles, which are published in this journal, are subject to the following terms in relation to the rights of patrimonial or exploitation:
- The authors will keep their copyright and guarantee to the journal the right of first publication of their work, which will be distributed with a Creative Commons BY-NC-SA 4.0 license that allows third parties to reuse the work whenever its author, quote the original source and do not make commercial use of it.
b. The authors may adopt other non-exclusive licensing agreements for the distribution of the published version of the work (e.g., deposit it in an institutional telematic file or publish it in a monographic volume) provided that the original source of its publication is indicated.
c. Authors are allowed and advised to disseminate their work through the Internet (e.g. in institutional repositories or on their website) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).
